Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Typesort descending $ Amount Activity Investigator Unit Sponsor Date
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS) Contract $167,627.92 Clinical Trial Christian Bime Medicine Kinevant Sciences, Inc. 10/2020
A Novel Polymeric Valve for Transcatheter Aortic Valve Replacement Contract $532,239.00 Research Marvin Slepian UAHS Research PolyNova Cardiovascular, LLC 12/2020
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced... Contract $100,897.00 Clinical Trial Setsuko Chambers Cancer Center Division GOG Foundation, Inc. 08/2020
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase Contract $664,687.53 Clinical Trial Hani Babiker Cancer Center Division PPD Investigator Services, LLC. 05/2020
Student Aid for Field Epidemiology Response (SAFER) - Pinal County Intergovernmental Agreement (IGA) Contract $299,814.00 Instruction Kristen Pogreba Brown Epidemiology and Biostatistics Pinal County, Arizona 09/2020
Behavior Change Smoking Cessation - Arizona Department of Administration Contract $45,000.00 Other Sponsored Activity Mark Martz Public Hlth Pract & Trans Rsch Arizona Department of Administration 09/2020
Alternative Anticoagulant and Biocompatibility Study & Heparin-Impella Surface Interaction with Heparin-Containing Purge Solutions Contract $288,559.00 Research Marvin Slepian UAHS Research ABIOMED, Inc. 11/2020
Total Shoulder Arthroplasty Multi-Center Registry Contract $603,643.00 Clinical Trial Joshua Hustedt COM Phx Orthopedics Arthrex, Incorporated 06/2020
Epitope Open-Label Extension Study to Evaluate the Long-Term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) Contract $173,290.72 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Pharmaceutical Research Associates 02/2020
A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Recept Contract $854,975.00 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 10/2020
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness Contract $1,003,039.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Eli Lilly and Company 09/2020
A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately Contract $395,132.40 Clinical Trial Sasha Taleban Medicine PPD Investigator Services, LLC. 05/2020
Arizona State Opioid Response II Grant - University of Arizona Contract $300,000.00 Research Maria Manriquez-Sanchez COM Phx Obstetrics&Gynecology Arizona Health Care Cost Containment System 11/2020
Zephyr Valve Registry (ZEVR) Contract $148,825.60 Clinical Trial Raed Alalawi COM Phx Internal Medicine Pulmonx Corporation 06/2020
FLowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) Contract $125,613.76 Clinical Trial Christopher Goettl COM Phx Radiology Inari Medical 02/2020
A Phase 2 Randomized Study of Adjuvant Immunotherapy with the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma Contract $206,150.52 Clinical Trial Montaser Shaheen Cancer Center Division PPD Investigator Services, LLC. 10/2020
Consumer Tools for Understanding Water Quality Contaminants and POU/POE Options Contract $49,978.00 Research Kelly Reynolds Community Environment & Policy Water Quality Research Foundation 12/2020
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus Disease (Covid Contract $503,260.68 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Pharmaceutical Research Associates 08/2020
Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w Contract $17,187.52 Clinical Trial Kresimira Milas Surgery Bard Peripheral Vascular, Inc. 05/2020
Assessing the Feasibility of Characterizing the Treatment and Survivorship Outcomes of Racial/Ethnic Minorities with IDD using SEER-Medicare Data Contract $7,500.00 Research Julie Armin Family and Community Medicine University of New Mexico 11/2020
Phase 1/1b Multicenter, Open-Label, First-in-Human Dose Escalation and Dose Expansion Study to Assess Safety and Tolerability of Orally Administered PMD-026 in Patients with Metastatic Breast Cancer w Contract $100,897.00 Clinical Trial Pavani Chalasani Cancer Center Division Phoenix Molecular Designs (Canada) 02/2020
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine in Participants Undergoing Surgeries that Include a Bowel Resection or Bowel Transection Contract $586,018.76 Clinical Trial Bellal Joseph Surgery Shionogi Inc 10/2020
COVID-19-C3PO: Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) Contract $1,222,500.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine University of Michigan 08/2020
Phase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer Contract $323,394.75 Clinical Trial Hani Babiker Cancer Center Division Vedanta Biosciences, Inc. 05/2020
Evaluate the Clinical and Economic Outcomes of Performing PD-L1 Test as an In-Vitro Diagnostic (IVD) Vs. as a Laboratory Developed Test (LDT) to Select Patients with Non-Small Cell Lung Cancer (NSCLC) Contract $61,080.00 Research Jason Hurwitz HOPE Center Ventana Medical Systems, Inc. 07/2020

Pages